Science

Finding new life in old chemicals for pharmaceuticals using light-driven chemistry

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 11/11/2026, 11:25:25 UTC.

Briefings

A research team discovered a method to repurpose existing sulfonamide drug libraries for new pharmaceutical applications by using light-driven chemistry. This approach allows for the chemical modification of thousands of sulfonamides that are otherwise difficult to alter, potentially expanding their utility in treating type 2 diabetes, hypertension, and inflammation. The study was published in November 2026 in a preprint repository.

Key points

• Researchers successfully modified thousands of sulfonamide compounds using light-driven chemistry to enable new pharmaceutical applications.
• The method addresses the limitation of existing sulfonamide libraries by enabling chemical modification where it was previously difficult.

Context

Drug companies maintain large libraries of chemical compounds for new pharmaceutical development. Sulfonamides are widely used in antibiotics and for treating type 2 diabetes, hypertension, and inflammation, but their utility is limited because they are difficult to chemically modify.

Limitations

The evidence is limited to a single paragraph describing the discovery of a new method. The study is presented as a preprint and does not include results from controlled experiments, clinical trials, or peer-reviewed publication. Specific dates for the preprint release are not provided, and the scope of the chemical modifications remains undefined.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 11/11/2026, 11:44:39 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeih4emoaneoaqee35ny5cmyzclx7gg3o2wwxjqwh2hfmyecrtppsmq